Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457196 · ClinicalTrials.gov registry record · NA
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2,798
- Enrollment target
NCT01457196 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 2,798 participants.
The verdict
NCT01457196, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,798 participants
- Enrollment target
Study Summary
The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.
Interventions
- DIAGNOSTIC_TEST Tumor Genetic Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,798 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457196
The ClinicalTrials.gov registry entry for NCT01457196 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,798 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor Genetic Sequencing is the first listed.
NCT01457196 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01457196 about?
NCT01457196 is a clinical study titled "Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions". The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support trea...
What is the current status of trial NCT01457196?
This trial is currently completed. It is a NA study. The enrollment target is 2,798 participants. The study started on 2011-09. Estimated completion is 2018-06-06.
What interventions are being tested in trial NCT01457196?
The interventions under investigation include: Tumor Genetic Sequencing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01457196?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.